Cholangiocarcinoma and dominant strictures in patients with primary sclerosing cholangitis: A 25-year single-centre experience

European Journal of Gastroenterology and Hepatology

Volumn 24, Issue 9, 2012, Pages 1051-1058

  Chapman, Michael H ^a,b   Webster, George J M ^a   Bannoo, Selina ^b   Johnson, Gavin J ^a   Wittmann, Johannes ^b   Pereira, Stephen P ^a,b  

^a UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

cholangiocarcinoma; dominant stricture; endoscopic retrograde cholangiopancreatography; primary sclerosing cholangitis

Indexed keywords

ADOLESCENT; ADULT; AGED; BILE DUCT CARCINOMA; BILE DUCT DILATATION; BILE DUCT OBSTRUCTION; CANCER RISK; CONTROLLED STUDY; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; ENDOSCOPIC THERAPY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; REVIEW; STENT; SURVIVAL RATE; TERTIARY HEALTH CARE; TREATMENT OUTCOME;

ADULT; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CHOLANGIOCARCINOMA; CHOLANGIOPANCREATOGRAPHY, ENDOSCOPIC RETROGRADE; CHOLANGITIS, SCLEROSING; CONSTRICTION, PATHOLOGIC; FEMALE; HUMANS; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; STENTS; TERTIARY CARE CENTERS; TREATMENT OUTCOME;

EID: 84864884444     PISSN: 0954691X     EISSN: 14735687     Source Type: Journal    
DOI: 10.1097/MEG.0b013e3283554bbf     Document Type: Review

References (23)

1. Gotthardt DN, Rudolph G, Kloters-Plachky P, Kulaksiz H, Stiehl A. Endoscopic dilation of dominant stenoses in primary sclerosing cholangitis: outcome after long-term treatment. Gastrointest Endosc 2010; 71: 527-534.
2. Bjornsson E, Lindqvist-Ottosson J, Asztely M, Olsson R. Dominant strictures in patients with primary sclerosing cholangitis. Am J Gastroenterol 2004; 99:502-508. (Pubitemid 38524130)
3. Tischendorf JJ, Hecker H, Kruger M, Manns MP, Meier P.N. Characterization, outcome, and prognosis in 273 patients with primary sclerosing cholangitis: a single center study. Am J Gastroenterol 2007; 102:107-114. (Pubitemid 46072050)
4. May GR, Bender CE, LaRusso NF, Wiesner R.H. Nonoperative dilatation of dominant strictures in primary sclerosing cholangitis. AJR 1985; 145: 1061-1064. (Pubitemid 16234125)
5. Van Milligen de Wit AW, Rauws EA, van Bracht J, Mulder CJ, Jones EA, Tytgat GN, et al. Lack of complications following short-term stent therapy for extrahepatic bile duct strictures in primary sclerosing cholangitis. Gastrointest Endosc 1997; 46:344-347. (Pubitemid 27459273)
6. Kaya M, Petersen BT, Angulo P, Baron TH, Andrews JC, Gostout CJ, et al. Balloon dilation compared to stenting of dominant strictures in primary sclerosing cholangitis. Am J Gastroenterol 2001; 96:1059-1066. (Pubitemid 32319137)
7. Baluyut AR, Sherman S, Lehman GA, Hoen H, Chalasani N. Impact of endoscopic therapy on the survival of patients with primary sclerosing cholangitis. Gastrointest Endosc 2001; 53:308-312. (Pubitemid 32207314)
8. Stiehl A, Rudolph G, Kloters-Plachky P, Sauer P,Walker S. Development of dominant bile duct stenoses in patients with primary sclerosing cholangitis treated with ursodeoxycholic acid: outcome after endoscopic treatment. J Hepatol 2002; 36:151-156. (Pubitemid 34146420)
9. Hammel P, Couvelard A, O'Toole D, Ratouis A, Sauvanet A, Flejou JF, et al. Regression of liver fibrosis after biliary drainage in patients with chronic pancreatitis and stenosis of the common bile duct. N Engl J Med 2001; 344:418-423. (Pubitemid 32128674)
10. Rudolph G, Gotthardt D, Kloters-Plachky P, Kulaksiz H, Rost D, Stiehl A. Influence of dominant bile duct stenoses and biliary infections on outcome in primary sclerosing cholangitis. J Hepatol 2009; 51:149-155.
11. Bergquist A, Ekbom A, Olsson R, Kornfeldt D, Loof L, Danielsson A, et al. Hepatic and extrahepatic malignancies in primary sclerosing cholangitis. J Hepatol 2002; 36:321-327. (Pubitemid 34194790)
12. Chapman RW, Arborgh BA, Rhodes JM, Summerfield JA, Dick R, Scheuer PJ, et al. Primary sclerosing cholangitis: a review of its clinical features, cholangiography, and hepatic histology. Gut 1980; 21:870-877. (Pubitemid 11198911)
13. Ponsioen CY, Lam K, van Milligen deWit AW, Huibregtse K, Tytgat G.N. Four years experience with short term stenting in primary sclerosing cholangitis. Am J Gastroenterol 1999; 94:2403-2407. (Pubitemid 29420664)
14. Chapman R, Fevery J, Kalloo A, Nagorney DM, Boberg KM, Shneider B, et al. Diagnosis and management of primary sclerosing cholangitis. Hepatology 2010; 51:660-678.
15. Beuers U, Boberg KM, Chapman RW, Chazouillè res O, Invernizzi P, Jones DE, et al. EASL Clinical Practice Guidelines: management of cholestatic liver diseases. J Hepatol 2009; 51:237-267.
16. Olsson R, Bjornsson E, Backman L, Friman S, Hockerstedt K, Kaijser B, et al. Bile duct bacterial isolates in primary sclerosing cholangitis: a study of explanted livers. J Hepatol 1998; 28:426-432. (Pubitemid 28133546)
17. Rerknimitr R, Fogel EL, Kalayci C, Esber E, Lehman GA, Sherman S. Microbiology of bile in patients with cholangitis or cholestasis with and without plastic biliary endoprosthesis. Gastrointest Endosc 2002; 56: 885-889. (Pubitemid 36236721)
18. Ponsioen CY, Vrouenraets SM, Prawirodirdjo W, Rajaram R, Rauws EA, Mulder CJ, et al. Natural history of primary sclerosing cholangitis and prognostic value of cholangiography in a Dutch population. Gut 2002; 51:562-566.
19. Van den Hazel SJ,Wolfhagen EH, van Buuren HR, van de Meeberg PC, Van Leeuwen D.J. Prospective risk assessment of endoscopic retrograde cholangiography in patients with primary sclerosing cholangitis. Dutch PSC Study Group. Endoscopy 2000; 32:779-782.
20. Williams EJ, Taylor S, Fairclough P, Hamlyn A, Logan RF, Martin D, et al. Risk factors for complication following ERCP; results of a large-scale, prospective multicenter study. Endoscopy 2007; 39:793-801. (Pubitemid 47386828)
21. Bangarulingam SY, Bjornsson E, Enders F, Barr Fritcher EG, Gores G, Halling KC, et al. Long-term outcomes of positive fluorescence in situ hybridization tests in primary sclerosing cholangitis. Hepatology 2010; 51:174-180.
22. Chapman MH, Tidswell R, Dooley JS, Sandanayake NS, Cerec V, Deheragoda M, et al. Whole genome RNA expression profiling of endoscopic biliary brushings provides data suitable for biomarker discovery in cholangiocarcinoma. J Hepatol 2012; 56:877-885.
23. Lewis JT, Talwalkar JA, Rosen CB, Smyrk TC, Abraham S.C. Precancerous bile duct pathology in end-stage primary sclerosing cholangitis, with and without cholangiocarcinoma. Am J Surg Pathol 2010; 34:27-34.